Big biotech, Big pharma, Biotech, Partnering, Pharma

Amgen biopharma partners for supporting startups

Posted on 23 December 2014

Tags: , ,

Amgen and LabCentral biopharma partners: announced an agreement in which Amgen has become a LabCentral platinum sponsor.

As part of the sponsorship agreement, Amgen can nominate up to two promising life-sciences and biotech startup companies per year to take up residence in LabCentral's Kendall Square facilities.

"Amgen, with its deep expertise as a developer of biotech-based drugs, is an ideal partner for many of LabCentral's resident companies working on promising new biopharmaceuticals," said LabCentral President Johannes Fruehauf, Ph.D., M.D.

Searching for more deal information? Current Partnering offers the following options:

  • CP Reports | Browse titles | Over 200 report titles that focus upon different deal types from licensing, co-promotion to distribution, biomarkers to drug delivery, oncology to psychiatry, all of which provide you with an insight into the latest life science deal making trends
  • Current Agreements | Login | Find out more | Updated daily by our industry analysts, our fully searchable life sciences intelligence database allows you to find deals and alliances dating as far back as 2000 saving you valuable time on your deal making research activities

 

"We're thrilled that Amgen has joined as our newest sponsor and look forward to working with the Amgen team to support these early-stage entrepreneurs and to help accelerate development of new therapies to improve human health."

For further deal information visit Current Agreements (subscription required)

Related

Scorecard: Top partnering deals by value in 2014

View: Top pharmaceutical companies

View: Top biotech companies

Report: Top 50 Big Pharma Partnering and M&A Deal Trends

Report: Top 50 Big Biotech Partnering and M&A Deal Trends

Print Friendly, PDF & Email

Leave a Reply